Inc. ("WuXi Biologics" or "the Group", stock code: 2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) service company offering end-to-end solutions for ...
Shortly after WuXi AppTec provided an upbeat outlook for 2025, several other WuXi sibling companies are coming forward with ...
WuXi Biologics reports 32.5% North American revenue growth in 2024, driven by deals with BioNTech and Candid Therapeutics, ...
The American Red Cross is issuing a national call to help ensure no one faces a disaster alone by donating on Red Cross Giving Day, March ...
Hillstar Bio, a leading biotechnology company focused on developing next-generation precision immunology therapies for autoimmune diseases, today announced the successful closing of a $67 million ...
3h
The global Drug Discovery Services Market , valued at US$14.89 billion in 2024, is forecasted to grow at a robust CAGR of ...
Bispecific antibodies (bsAbs) represent a significant advancement in biologic therapeutics, offering enhanced therapeutic efficacy through dual antigen tar | Ebooks ...
Besmile at IDS 2025: Unleashing 24/7 Unmanned Milling Machine and Next Gen Zirconia for Smarter Labs
Besmile introduced new solutions to tackle challenges in modern dental manufacturing settings. With highlighted advancements ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback